These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 13602773)

  • 41. [Effect of drug resistance of Mycobacterium tuberculosis on the therapeutic results of a drug to which sensitivity is retained(experimental data)].
    Belogurova VP; Ivanitskaia NN
    Antibiotiki; 1970 Feb; 15(2):154-7. PubMed ID: 4986204
    [No Abstract]   [Full Text] [Related]  

  • 42. Development of isoniazid-NAD truncated adducts embedding a lipophilic fragment as potential bi-substrate InhA inhibitors and antimycobacterial agents.
    Delaine T; Bernardes-Génisson V; Quémard A; Constant P; Meunier B; Bernadou J
    Eur J Med Chem; 2010 Oct; 45(10):4554-61. PubMed ID: 20696503
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of phthivazid and isoniazid on the macro- and microorganisms in tubercular infections].
    Sodikov ES; Kazakov KS; Gapon'ko LA
    Probl Tuberk; 1970; 48(8):58-61. PubMed ID: 4924910
    [No Abstract]   [Full Text] [Related]  

  • 44. [Chemical structure and antibacterial action of isoniazid analogs].
    KAKIMOTO S; KRUEGER-THIEMER E; WEMPE E
    Arzneimittelforschung; 1960 Dec; 10():963-7. PubMed ID: 13750826
    [No Abstract]   [Full Text] [Related]  

  • 45. [Experimental studies of anti-tuberculous effect of phthivaside].
    ZEBROWSKI T; PIENIAZEK J; TROJANOWSKI S; BOROWIECKA A
    Pol Tyg Lek (Wars); 1957 Sep; 12(36):1390-3. PubMed ID: 13505232
    [No Abstract]   [Full Text] [Related]  

  • 46. Synthesis and antimycobacterial activity of a novel series of isonicotinylhydrazide derivatives.
    Jaju S; Palkar M; Maddi VS; Ronad P; Mamledesai S; Satyanarayana D; Ghatole M
    Arch Pharm (Weinheim); 2009 Dec; 342(12):723-31. PubMed ID: 19899098
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro and in vivo activities of acylated derivatives of isoniazid against mycobacterium tuberculosis.
    Hearn MJ; Cynamon MH
    Drug Des Discov; 2003; 18(4):103-8. PubMed ID: 15553921
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Tuberculostatic activity of isonicotylamino-I, dimethyl-2,5, pyrrol (G.144), a structural analogue of isoniazid].
    GAZAVE JM; BUU-HOI NP; XUONG ND
    Therapie; 1957; 12(4):486-92. PubMed ID: 13467825
    [No Abstract]   [Full Text] [Related]  

  • 49. [Treatment of tuberculous meningitis with the p-amino-salicylate of isoniazid (Dipasic)].
    ALONSO LOMAS L; ARIAS MARTINEZ J; AGOTE POVEDA IP
    Med Esp; 1960 Aug; 44():125-32. PubMed ID: 13682657
    [No Abstract]   [Full Text] [Related]  

  • 50. [Variability of the polyresistance of the tubercle bacillus. I. Sensitivity to the paminosalicylic salt of isoniazid].
    VIALLIER J; CAYRE RM
    C R Seances Soc Biol Fil; 1958; 152(7):1127-9. PubMed ID: 13619195
    [No Abstract]   [Full Text] [Related]  

  • 51. Screening of isoniazid inactivators by dilution test.
    Hodgkin MM; Eidus L; Hamilton EJ
    Bull World Health Organ; 1974; 51(4):428-30. PubMed ID: 4549494
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A case of poisoning caused by a lethal dose of isonicotinic acid hydrazid].
    BANCER D
    Pol Tyg Lek (Wars); 1959 Jan; 14(1):26-7. PubMed ID: 13667501
    [No Abstract]   [Full Text] [Related]  

  • 53. [On the therapeutic use of sulfoniazid in tuberculosis].
    COVACEV L
    Minerva Med; 1961 Mar; 52():1059-64. PubMed ID: 13696068
    [No Abstract]   [Full Text] [Related]  

  • 54. 1H and 13C NMR characterization of pyridinium-type isoniazid-NAD adducts as possible inhibitors of InhA reductase of Mycobacterium tuberculosis.
    Broussy S; Bernardes-Génisson V; Coppel Y; Quémard A; Bernadou J; Meunier B
    Org Biomol Chem; 2005 Feb; 3(4):670-3. PubMed ID: 15703806
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Sulfoniazide].
    SCEVOLA G
    Minerva Med; 1957 Dec; 48(97):4132-6. PubMed ID: 13503932
    [No Abstract]   [Full Text] [Related]  

  • 56. [Certain experimental data on the effect of phthivazide and tubazide on the macrooganism].
    IZABOLINSKAIA RM; KOGOSOVA LS
    Biull Eksp Biol Med; 1959 Oct; 48():56-9. PubMed ID: 14406188
    [No Abstract]   [Full Text] [Related]  

  • 57. [Clinical contribution to the use of sulfonazid in the therapy of "febriculas"].
    ZOLI A
    Riv Crit Clin Med; 1959 Dec; 59():744-64. PubMed ID: 13847721
    [No Abstract]   [Full Text] [Related]  

  • 58. [Maleinic acid hydrazid & maleinic acid phenylhydrazid, 2 new antituberculotics].
    JENEY E; ZSOLNAI T
    Schweiz Z Tuberc Pneumonol; 1958; 15(3):175-82. PubMed ID: 13602773
    [No Abstract]   [Full Text] [Related]  

  • 59. [Maleic hydrazide and maleic-phenylhydrazide, two new antituberculotics].
    JENEY E; ZSOLNAI T
    Tuberkulozis; 1957; 10(10-12):216-9. PubMed ID: 13557018
    [No Abstract]   [Full Text] [Related]  

  • 60. [The molecular compound para-aminosalicylic acid+isonicotinic acid hydrazid].
    FISCHER R; KARTNIG T
    Mikroskopie; 1958 Sep; 13(3-4):111-3. PubMed ID: 13612809
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.